Total Payments
$649.37
2024 Payments
$466.12
Companies
18
Transactions
28
Medicare Patients
266
Medicare Billing
$24,049
Payment Breakdown by Category
Food & Beverage$553.37 (85.2%)
Education$96.00 (14.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $553.37 | 27 | 85.2% |
| Education | $96.00 | 1 | 14.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $111.31 | 2 | $0 (2024) |
| GENZYME CORPORATION | $86.93 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $63.10 | 3 | $0 (2024) |
| PFIZER INC. | $46.99 | 3 | $0 (2024) |
| Genentech USA, Inc. | $46.41 | 2 | $0 (2024) |
| Celgene Corporation | $35.28 | 2 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $33.14 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $29.92 | 1 | $0 (2024) |
| TAIHO ONCOLOGY, INC. | $28.80 | 1 | $0 (2024) |
| Eisai Inc. | $23.09 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $466.12 | 19 | Gilead Sciences, Inc. ($96.00) |
| 2023 | $183.25 | 9 | GENZYME CORPORATION ($70.12) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Oncology | ||||||
| 10/24/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Oncology | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.87 | General |
| 08/13/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Oncology | ||||||
| 08/03/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: DESMOID TUMORS | ||||||
| 05/02/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Oncology | ||||||
| 04/23/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $33.14 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/18/2024 | Genentech USA, Inc. | Kadcyla (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: BioOncology | ||||||
| 04/17/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: ONCOLOGY | ||||||
| 04/16/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.08 | General |
| 03/21/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: BioOncology | ||||||
| 03/19/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: ONCOLOGY | ||||||
| 03/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.01 | General |
| 03/05/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Education | In-kind items and services | $96.00 | General |
| Category: ONC | ||||||
| 03/04/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $19.35 | General |
| Category: Hematology | ||||||
| 12/05/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.31 | General |
| 11/30/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $23.09 | General |
| Category: Oncology | ||||||
| 11/16/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.93 | General |
| Category: Hematology | ||||||
| 11/15/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $24.61 | General |
| 11/14/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $18.61 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 214 | 328 | $56,817 | $18,597 |
| 2021 | 1 | 19 | 39 | $4,329 | $1,186 |
| 2020 | 2 | 33 | 90 | $12,611 | $4,267 |
Total Patients
266
Total Services
457
Medicare Billing
$24,049
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 149 | 249 | $44,073 | $14,829 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 31 | 39 | $4,524 | $1,595 | 35.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 13 | $3,198 | $1,152 | 36.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 21 | 27 | $5,022 | $1,021 | 20.3% |
| 99334 | Established patient assisted living visit, typically 15 minutes | Office | 2021 | 19 | 39 | $4,329 | $1,186 | 27.4% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2020 | 15 | 45 | $7,745 | $2,615 | 33.8% |
| 99334 | Established patient assisted living visit, typically 15 minutes | Office | 2020 | 18 | 45 | $4,866 | $1,652 | 33.9% |
About Jamie Meyer, NP
Jamie Meyer, NP is a Gerontology healthcare provider based in Reed City, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1043692932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jamie Meyer, NP has received a total of $649.37 in payments from pharmaceutical and medical device companies, with $466.12 received in 2024. These payments were reported across 28 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($553.37).
As a Medicare-enrolled provider, Meyer has provided services to 266 Medicare beneficiaries, totaling 457 services with total Medicare billing of $24,049. Data is available for 3 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Gerontology
- Location Reed City, MI
- Active Since 06/26/2015
- Last Updated 05/19/2023
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1043692932
Products in Payments
- Trodelvy (Drug) $96.00
- IBRANCE (Drug) $46.99
- SARCLISA (Biological) $43.71
- ZEPZELCA (Drug) $33.14
- KEYTRUDA (Biological) $29.92
- LONSURF (Drug) $28.80
- TAGRISSO (Drug) $26.75
- Kadcyla (Biological) $26.29
- Lenvima (Drug) $23.09
- OGSIVEO (Drug) $22.01
- CALQUENCE (Drug) $20.48
- Venclexta (Biological) $20.12
- Pomalyst (Drug) $19.35
- Enhertu (Drug) $18.94
- JEMPERLI (Biological) $18.17
- ALUNBRIG (Drug) $17.93
- RYBREVANT (Drug) $16.43
- REBLOZYL (Biological) $15.93
- Padcev (Drug) $13.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.